MALAT1 and nonpapillary renal cell carcinoma: MALAT1 has also been demonstrated to promote EMT in ccRCC cells by functioning as a competing endogenous RNA (ceRNA) and preventing miRNA-mediated degradation of the transcript-encoding zinc finger E box binding homeobox 2 (ZEB2), a transcriptional regulator of E-cadherin [14].